Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.